TIFFANY PARKER: Open Payments
NPI 1497937197 · MINDEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 68 payments from 13 companies in 2025. Trend: 2023 $1,705 · 2024 $1,298 · 2025 $1,316
Food & beverage: $1,244Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $253 |
| ABBVIE INC. | 15 | $198 |
| Lilly USA, LLC | 9 | $182 |
| GENZYME CORPORATION | 8 | $182 |
| PFIZER INC. | 6 | $146 |
| UCB, Inc. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| Amgen Inc. | 2 | $40 |
| Incyte Corporation | 2 | $36 |
Products named: TREMFYA, DUPIXENT, RINVOQ, TALTZ, CIBINQO, Bimzelx, Zoryve, Rhapsido.
Industry payments across LA — which companies pay providers there.
